With so little number of shares available and with what we have in the pipeline, if a CR were to eventuate I would expect it at a premium to the current price.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025